Data as of Apr 17
| -0.02 / -1.98%|
The 1 analysts offering 12-month price forecasts for Implant Sciences Corp have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +51.52% increase from the last price of 0.99.
The current consensus among 2 polled investment analysts is to Buy stock in Implant Sciences Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.